Prognostic significance of neuropsychological tests in patients with typical remitting multiple sclerosis
Abstract
The purpose of the research was to study the prognostic value of clinical and neuropsychological characteristics of the pathological process at a typical rhythmic PC for 5 years longtime illness prediction. The research of the cognitive function was held with the use of quantitative (A. R. Luriya tests) and qualitative assessment methods (verbal and colorStroop test, Encryption test). The retrospective analysis showed that cognitive disturbances, even subclinical, displayed in the form of neuropsychological test s changing, are authentically bound with the more likely of secondary progressing and at a prime PS weight according to the EDSS scale. Among the used neuropsychological tests the most sensing and informative in respect of the forecast of PS weight for the next 5 years is the Stroop test.
About the Authors
A. N. Boyko
Scientific Research Institute of Pediatrics of Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
B. T. Mugutdinova
Scientific Research Institute of Pediatrics of Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
T. M. Mugutdinov
Dagestan State Medical University
Russian Federation
Russian Federation
References
1. Алексеева Т. Г., Бойко А. Н., Гусев Е. И. Спектр нейропсихологических изменений при рассеянном склерозе. Ж. Неврологии и психиатрии 2000, 11: 15-20.
2. Алексеева Т. Г., Ениколопова Е. В., Садальская Е. В., и соавт. Комплексный подход к оценке когнитивной и эмоционально-личностной сфер у больных рассеянным склерозом. Ж. невр. псих. 2002, Спец. выпуск «Рассеянный склероз»: 20-26.
3. Г усев Е. И., Бойко А. Н., Завалишин И. А. и др. Эпидемиологические исследования рассеянного склероза. Метод. рекомендации МЗ РФ № 2003/82. М., 2003.
4. Гусев Е. И., Бойко А. Н. Рассеянный склероз: достижения десятилетия. Ж. неврологии и психиатрии 2007, 4: 4-13.
5. Лурия А. Р. Высшие корковые функции человека. М., МГУ, 1969.
6. Alekseeva T. G., Boyko A. N., Gusev E. I. Spectr neyropsichologicheskih izmeneniy pri rasseyannom skleroze [The range of neuropsychological changes at multiple sclerosis] // Nevrologiya i psychiatriya. 2000, 11: 15-20.
7. Alekseeva T. G., Enikolopova E. V., Sadal’skaya E.V., etc. Kompleksniy podhod k ocenke cognitivnoy I emocional’no- lichnostnoy sfer u bol'nikh rasseyannim sklerozom. [The complex approach to evaluate the cognitive and emotional spheres with the multiple sclerosis people] // Nevrologiya i psikhiatriya 2002, spec.“ Multiple scleros'is”: 20-26.
8. Gusev E. I., Boyko A.N., Zavalishin I. A., etc. Epidemiologicheskie issledovaniya rasseyannogo skleroza [Epidemic researches of multiple sclerosis] // Metod. recomendacii MZ RF № 2003/82. М, 2003.
9. Gusev E. I., Boyko A. N. Rasseyanniy skleroz: dostizheniya desyatiletiya. [Multiple sclerosis: results of decade] // Nevrologiya i psikhiatriya 2007, 4: 4-13.
10. Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002, 16: 381-397.
11. Boyko A, Kesselring J, Paty DW, et al. Multiple sclerosis and public health. Educational and management implications. World Health Organization, Department of Mental Health, Neuroscience and Neurological Disorders, 1999, (2), 1-11.
12. Brassington J. C., Marsh N. V. Neuropsychological aspects of multiple sclerosis. Neuropsychology Rev 1998, 8: 43-77.
13. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-1438.
14. Confavreux C, Vukusic S. The clinical epidemiology of multiple sclerosis. Neuroimaging Clin N Am. 2008 18: 589-622.
15. Dean G. How many people in the world have multiple sclerosis? Neuroepidemiology 1994; 13: 1-7.
16. Gusev E. I., Boyko A. N., Bykova O. V., et al. The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver // Clinical Neurology and Neurosurgery 2002, 104: 203-207.
17. Koch-Henriksen N, S0rensen PS.The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010; 9: 520-532.
18. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33: 1444-1452.
19. Luria A. R. Visshie korkovie funkcii [The highest cortical functions] М., MSU, 1969.
20. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
21. Polman C. H., Reingold S. C., Edan G. et al. Diagnostic criteria for multiple sclerosis: 2005 revision to the “McDonald Criteria”. Ann Neurol2005, 58: 840-846.
22. Rao SM, Leo GJ, Bernadin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction. Neurology 1991, 41: 685-691.
23. Rao SM, Leo GJ, Bernadin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991, 41: 692-696.
24. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989; 112: 133-146.
25. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996; 14: 291-308.
Review
For citations:
Boyko A.N., Mugutdinova B.T., Mugutdinov T.M. Prognostic significance of neuropsychological tests in patients with typical remitting multiple sclerosis. Medical alphabet. 2018;2(17):13-18. (In Russ.)
Views:
282
Email this article 